Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Vaccine
|
August 6, 2011
The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression
Craig Laferriere
Expert Review of Vaccines
|
June 8, 2026
Progress towards an Epstein-Barr virus vaccine
Craig Laferriere, Elliot Bland, Wayne Channon, et al.
Glycoconjugate Journal
|
August 19, 2011
Experimental design to optimize an Haemophilus influenzae type b conjugate vaccine made with hydrazide-derivatized tetanus toxoid
Craig Laferriere, Neil Ravenscroft, Seanette Wilson, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
July 8, 2018
Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
Mark Atwood, Linda Beausoleil, Marie-Claude Breton, et al.
Canadian Respiratory Journal
|
July 23, 2016
A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada
Shelly A McNeil, Nawab Qizilbash, Jian Ye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2018
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
Heather L Sings, Philippe De Wals, Bradford D Gessner, et al.
Clinical and Diagnostic Laboratory Immunology
|
November 11, 2003
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae
Sandra Romero-Steiner, Carl Frasch, Nelydia Concepcion, et al.
BMJ Open Respiratory Research
|
March 20, 2020
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
Jason LeBlanc, May ElSherif, Lingyun Ye, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Vaccine
|
August 6, 2011
The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression
Craig Laferriere
Expert Review of Vaccines
|
June 8, 2026
Progress towards an Epstein-Barr virus vaccine
Craig Laferriere, Elliot Bland, Wayne Channon, et al.
Glycoconjugate Journal
|
August 19, 2011
Experimental design to optimize an Haemophilus influenzae type b conjugate vaccine made with hydrazide-derivatized tetanus toxoid
Craig Laferriere, Neil Ravenscroft, Seanette Wilson, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
July 8, 2018
Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
Mark Atwood, Linda Beausoleil, Marie-Claude Breton, et al.
Canadian Respiratory Journal
|
July 23, 2016
A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada
Shelly A McNeil, Nawab Qizilbash, Jian Ye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2018
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
Heather L Sings, Philippe De Wals, Bradford D Gessner, et al.
Clinical and Diagnostic Laboratory Immunology
|
November 11, 2003
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae
Sandra Romero-Steiner, Carl Frasch, Nelydia Concepcion, et al.
BMJ Open Respiratory Research
|
March 20, 2020
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
Jason LeBlanc, May ElSherif, Lingyun Ye, et al.
Page
of 1